Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa

Peer Review reports

Original Submission
16 Feb 2007	Submitted	Original manuscript
8 Mar 2007	Reviewed	Reviewer Report - Guido Silvestri
8 Mar 2007	Reviewed	Reviewer Report - Ludo Lavreys
23 Mar 2007	Author responded	Author comments - Stephen Lawn
Resubmission - Version 2
23 Mar 2007	Submitted	Manuscript version 2
19 Apr 2007	Reviewed	Reviewer Report - Guido Silvestri
19 Apr 2007	Reviewed	Reviewer Report - Ludo Lavreys
17 May 2007	Author responded	Author comments - Stephen Lawn
Resubmission - Version 3
17 May 2007	Submitted	Manuscript version 3
Publishing
17 May 2007	Editorially accepted
17 May 2007	Article published	10.1186/1471-2334-7-41

Back to article page